Lysosome and HER3 (ErbB3) selective anticancer agent Kahalalide F: Semisynthetic modifications and antifungal lead-exploration studies

Abbas Gholipour Shilabin; Noer Kasanah; David E. Wedge; Mark T. Hamann

doi:10.1021/jm061288r

Lysosome and HER3 (ErbB3) selective anticancer agent Kahalalide F: Semisynthetic modifications and antifungal lead-exploration studies

Abbas Gholipour Shilabin
, Noer Kasanah
, David E. Wedge
, Mark T. Hamann

Department of Chemistry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4340-4350
Number of pages	11
Journal	Journal of Medicinal Chemistry
Volume	50
Issue number	18
DOIs	https://doi.org/10.1021/jm061288r
State	Published - Sep 6 2007

ASJC Scopus Subject Areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/jm061288r

Cite this

@article{cade480b338846af92e2a2e4f76dc884,

title = "Lysosome and HER3 (ErbB3) selective anticancer agent Kahalalide F: Semisynthetic modifications and antifungal lead-exploration studies",

author = "Shilabin, \{Abbas Gholipour\} and Noer Kasanah and Wedge, \{David E.\} and Hamann, \{Mark T.\}",

year = "2007",

month = sep,

day = "6",

doi = "10.1021/jm061288r",

language = "English",

volume = "50",

pages = "4340--4350",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

number = "18",

}

TY - JOUR

T1 - Lysosome and HER3 (ErbB3) selective anticancer agent Kahalalide F

T2 - Semisynthetic modifications and antifungal lead-exploration studies

AU - Shilabin, Abbas Gholipour

AU - Kasanah, Noer

AU - Wedge, David E.

AU - Hamann, Mark T.

PY - 2007/9/6

Y1 - 2007/9/6

UR - https://www.scopus.com/pages/publications/34548502668

UR - https://www.scopus.com/pages/publications/34548502668#tab=citedBy

U2 - 10.1021/jm061288r

DO - 10.1021/jm061288r

M3 - Article

C2 - 17696332

AN - SCOPUS:34548502668

SN - 0022-2623

VL - 50

SP - 4340

EP - 4350

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 18

ER -

Lysosome and HER3 (ErbB3) selective anticancer agent Kahalalide F: Semisynthetic modifications and antifungal lead-exploration studies

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this